Investigating the Preferences and Requirements of Patients and Healthcare Providers for a Physical Activity Program During Chemotherapy for Breast Cancer - Top-Institutions - MDSpire

Investigating the Preferences and Requirements of Patients and Healthcare Providers for a Physical Activity Program During Chemotherapy for Breast Cancer

  • By

  • D. Carolina Andrade

  • Loni Parrish

  • Courtney Harriss

  • Lindsay L. Peterson

  • Ryan P. Duncan

  • Jingqin Luo

  • Maura M. Kepper

  • Christine Marx

  • Mary C. Politi

  • Elizabeth A. Salerno

  • December 12, 2025

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Medical Oncology
    • Cancer Rehabilitation
    • Behavioral Medicine

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Medical Oncology
    • Rehabilitation Medicine
    • Exercise Oncology

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Medical Oncology
    • Physical Medicine and Rehabilitation
    • Psycho-oncology

  • #4

    Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of Medicine

    St. Louis, MO

    Key Differentiators

    • Oncology
    • Rehabilitation Medicine
    • Behavioral Health

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Medical Oncology
    • Rehabilitation Medicine
    • Exercise Science

Original Source(s)

Investigating the Preferences and Requirements of Patients and Healthcare Providers for a Physical Activity Program During Chemotherapy for Breast Cancer

  • by D. Carolina Andrade, Loni Parrish, Courtney Harriss, Lindsay L. Peterson, Ryan P. Duncan, Jingqin Luo, Maura M. Kepper, Christine Marx, Mary C. Politi, Elizabeth A. Salerno

  • December 12, 2025

Related Content

Trametinib as second-line therapy for advanced KRAS G12C-mutant non-small cell lung cancer: a single-center clinical analysis of 20 cases

A patient with triple-negative breast cancer developed acute myocardial infarction after docetaxel chemotherapy: case report and literature review

Gastric-type endocervical adenocarcinoma with Peutz-Jeghers syndrome: a case report and literature review